Literature DB >> 30130647

Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data.

Jorge Samper-González1, Ninon Burgos2, Simona Bottani3, Sabrina Fontanella3, Pascal Lu3, Arnaud Marcoux3, Alexandre Routier3, Jérémy Guillon3, Michael Bacci2, Junhao Wen2, Anne Bertrand4, Hugo Bertin5, Marie-Odile Habert6, Stanley Durrleman2, Theodoros Evgeniou7, Olivier Colliot8.   

Abstract

A large number of papers have introduced novel machine learning and feature extraction methods for automatic classification of Alzheimer's disease (AD). However, while the vast majority of these works use the public dataset ADNI for evaluation, they are difficult to reproduce because different key components of the validation are often not readily available. These components include selected participants and input data, image preprocessing and cross-validation procedures. The performance of the different approaches is also difficult to compare objectively. In particular, it is often difficult to assess which part of the method (e.g. preprocessing, feature extraction or classification algorithms) provides a real improvement, if any. In the present paper, we propose a framework for reproducible and objective classification experiments in AD using three publicly available datasets (ADNI, AIBL and OASIS). The framework comprises: i) automatic conversion of the three datasets into a standard format (BIDS); ii) a modular set of preprocessing pipelines, feature extraction and classification methods, together with an evaluation framework, that provide a baseline for benchmarking the different components. We demonstrate the use of the framework for a large-scale evaluation on 1960 participants using T1 MRI and FDG PET data. In this evaluation, we assess the influence of different modalities, preprocessing, feature types (regional or voxel-based features), classifiers, training set sizes and datasets. Performances were in line with the state-of-the-art. FDG PET outperformed T1 MRI for all classification tasks. No difference in performance was found for the use of different atlases, image smoothing, partial volume correction of FDG PET images, or feature type. Linear SVM and L2-logistic regression resulted in similar performance and both outperformed random forests. The classification performance increased along with the number of subjects used for training. Classifiers trained on ADNI generalized well to AIBL and OASIS. All the code of the framework and the experiments is publicly available: general-purpose tools have been integrated into the Clinica software (www.clinica.run) and the paper-specific code is available at: https://gitlab.icm-institute.org/aramislab/AD-ML.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Classification; Magnetic resonance imaging; Open-source; Positron emission tomography; Reproducibility

Mesh:

Substances:

Year:  2018        PMID: 30130647     DOI: 10.1016/j.neuroimage.2018.08.042

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  26 in total

1.  Reproducible Evaluation of Diffusion MRI Features for Automatic Classification of Patients with Alzheimer's Disease.

Authors:  Junhao Wen; Jorge Samper-González; Simona Bottani; Alexandre Routier; Ninon Burgos; Thomas Jacquemont; Sabrina Fontanella; Stanley Durrleman; Stéphane Epelbaum; Anne Bertrand; Olivier Colliot
Journal:  Neuroinformatics       Date:  2021-01

2.  A practical computerized decision support system for predicting the severity of Alzheimer's disease of an individual.

Authors:  Magda Bucholc; Xuemei Ding; Haiying Wang; David H Glass; Hui Wang; Girijesh Prasad; Liam P Maguire; Anthony J Bjourson; Paula L McClean; Stephen Todd; David P Finn; KongFatt Wong-Lin
Journal:  Expert Syst Appl       Date:  2019-04-10       Impact factor: 6.954

3.  Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study.

Authors:  Martin Nørgaard; Melanie Ganz; Claus Svarer; Vibe G Frokjaer; Douglas N Greve; Stephen C Strother; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-01       Impact factor: 6.200

4.  A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment.

Authors:  Min Wang; Zhuangzhi Yan; Shu-Yun Xiao; Chuantao Zuo; Jiehui Jiang
Journal:  Behav Neurol       Date:  2020-08-18       Impact factor: 3.342

5.  Multi-scale semi-supervised clustering of brain images: Deriving disease subtypes.

Authors:  Junhao Wen; Erdem Varol; Aristeidis Sotiras; Zhijian Yang; Ganesh B Chand; Guray Erus; Haochang Shou; Ahmed Abdulkadir; Gyujoon Hwang; Dominic B Dwyer; Alessandro Pigoni; Paola Dazzan; Rene S Kahn; Hugo G Schnack; Marcus V Zanetti; Eva Meisenzahl; Geraldo F Busatto; Benedicto Crespo-Facorro; Romero-Garcia Rafael; Christos Pantelis; Stephen J Wood; Chuanjun Zhuo; Russell T Shinohara; Yong Fan; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite; Nikolaos Koutsouleris; Daniel H Wolf; Christos Davatzikos
Journal:  Med Image Anal       Date:  2021-11-11       Impact factor: 8.545

6.  Early-Stage Alzheimer's Disease Categorization Using PET Neuroimaging Modality and Convolutional Neural Networks in the 2D and 3D Domains.

Authors:  Ahsan Bin Tufail; Nazish Anwar; Mohamed Tahar Ben Othman; Inam Ullah; Rehan Ali Khan; Yong-Kui Ma; Deepak Adhikari; Ateeq Ur Rehman; Muhammad Shafiq; Habib Hamam
Journal:  Sensors (Basel)       Date:  2022-06-18       Impact factor: 3.847

7.  Anomaly detection for the individual analysis of brain PET images.

Authors:  Ninon Burgos; M Jorge Cardoso; Jorge Samper-González; Marie-Odile Habert; Stanley Durrleman; Sébastien Ourselin; Olivier Colliot
Journal:  J Med Imaging (Bellingham)       Date:  2021-04-05

Review 8.  Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.

Authors:  Dallas P Veitch; Michael W Weiner; Paul S Aisen; Laurel A Beckett; Charles DeCarli; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Susan M Landau; John C Morris; Ozioma Okonkwo; Richard J Perrin; Ronald C Petersen; Monica Rivera-Mindt; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; Duygu Tosun; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2021-09-28       Impact factor: 16.655

9.  Multivariate prediction of functional outcome using lesion topography characterized by acute diffusion tensor imaging.

Authors:  Eric Moulton; Romain Valabregue; Stéphane Lehéricy; Yves Samson; Charlotte Rosso
Journal:  Neuroimage Clin       Date:  2019-04-10       Impact factor: 4.881

10.  Quantifying Neurodegenerative Progression With DeepSymNet, an End-to-End Data-Driven Approach.

Authors:  Danilo Pena; Arko Barman; Jessika Suescun; Xiaoqian Jiang; Mya C Schiess; Luca Giancardo
Journal:  Front Neurosci       Date:  2019-10-04       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.